Janux Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC JANX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

390,506

Value ($000)

5,389

Weight

0.0%

2021 Q3 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,389	0.0%	390,506	12/31/2025
2025 Q3	11/10/2025	8,665	0.0%	354,544	9/30/2025
2025 Q2	8/12/2025	6,916	0.0%	299,377	6/30/2025
2025 Q1	9/15/2025	7,388	0.0%	273,643	3/31/2025
2024 Q4	2/6/2025	14,624	0.0%	273,135	12/31/2024
2024 Q3	11/12/2024	10,639	0.0%	234,191	9/30/2024
2024 Q2	8/12/2024	3,247	0.0%	77,516	6/30/2024
2024 Q1	5/9/2024	1,855	0.0%	49,258	3/31/2024
2023 Q4	2/6/2024	495	0.0%	46,141	12/31/2023
2023 Q3	11/8/2023	491	0.0%	48,750	9/30/2023
2023 Q2	8/10/2023	547	0.0%	46,121	6/30/2023
2023 Q1	5/12/2023	549	0.0%	45,392	3/31/2023
2022 Q4	2/13/2023	628	0.0%	47,690	12/31/2022
2022 Q3	11/14/2022	631	0.0%	46,563	9/30/2022
2022 Q2	8/15/2022	520	0.0%	42,510	6/30/2022
2022 Q1	5/13/2022	637	0.0%	44,400	3/31/2022
2021 Q4	2/11/2022	670	0.0%	33,946	12/31/2021
2021 Q3	11/16/2021	705	0.0%	32,576	9/30/2021